Rubicon Research (NSE:RUBICON) Buyback Yield %: -2.04 (As of Jul. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:RUBICON Rubicon Research Ltd NSE:RUBICON
18 GF Score
Price ₹1,439.60
! 3 Warning Signs
View Full Analysis

What is Rubicon Research Buyback Yield %?

Rubicon Research NSE:RUBICON +1.45% 18 Buyback Yield % is -2.04 as of Jul. 20, 2026. GuruFocus rates NSE:RUBICON with a GF Score™ of 18/100. The stock has 3 warning signs investors should review. Among 291 Drug Manufacturers companies, Rubicon Research ranks worse than 58.76% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Rubicon Research's current buyback yield was -2.04%.

Rubicon Research Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Rubicon Research's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rubicon Research Buyback Yield % Chart

Rubicon Research Annual Data
Trend Mar23 Mar24 Mar25 Mar26
Buyback Yield %
0.00 0.00 0.00 -3.80

Rubicon Research Quarterly Data
Mar23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 -3.80

NSE:RUBICON vs LLY, JNJ, ABBV: Buyback Yield % Comparison

For the Drug Manufacturers - General subindustry, Rubicon Research's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rubicon Research Buyback Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rubicon Research's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Rubicon Research's Buyback Yield % falls into.


NSE:RUBICON
18GF Score
Rubicon Research Ltd NSE:RUBICON
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rubicon Research Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Rubicon Research's Buyback Yield for the fiscal year that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 4832.21) / 127318.8
=-3.80%

Rubicon Research's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 4832.21) / 127318.8
=-3.80%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -2.04 mean?
Rubicon Research (NSE:RUBICON) has a Buyback Yield % of -2.04 as of Jul. 20, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Rubicon Research and its competitors. According to the industry distribution chart, Rubicon Research ranks #171 out of 291 companies in the Drug Manufacturers industry, placing it in the top 58.8%.
Is Rubicon Research's Buyback Yield % too high?
Rubicon Research's current Buyback Yield % is -2.04. Based on the distribution chart, Rubicon Research ranks #171 out of 291 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Rubicon Research has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Rubicon Research's Buyback Yield % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Rubicon Research ranks #171 out of 291 companies for Buyback Yield %. This places Rubicon Research in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Drug Manufacturers company?
A good Buyback Yield % depends on the Drug Manufacturers industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Rubicon Research and its competitors. Rubicon Research's current Buyback Yield % is -2.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rubicon Research stock overvalued right now?
Rubicon Research (NSE:RUBICON) has a current Buyback Yield % of -2.04. The current Buyback Yield % is -2.04. Rubicon Research's overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Rubicon Research (NSE:RUBICON), the current Buyback Yield % is -2.04 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rubicon Research Business Description

Other Exchanges 544578:India
Address Road No. 33, MedOne House, B-75, Wagle Estate, Thane West, Thane, MH, IND, 400 604
Rubicon Research Ltd is a pharmaceutical formulations company specializing in developing, manufacturing, and marketing branded specialty and generic prescription products. Starting as a provider of contract formulation development services, the company expanded to operate an oral solids manufacturing facility in India, offering contract development and manufacturing services for regulated markets. The company's diverse product portfolio covers multiple therapeutic areas, including analgesics and pain management, CVS, CNS, hypokalemia, skeletal muscle relaxants, NRT, gastrointestinal, metabolic, and immunosuppressants. The company operates in India, the USA, and other markets, with the majority of its revenue coming from the USA.
18GF Score

Get the complete analysis for NSE:RUBICON

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,439.60
Price